Vaccination against cytomegalovirus: Still at base camp?
- PMID: 29894027
- DOI: 10.1111/ajt.14969
Vaccination against cytomegalovirus: Still at base camp?
Keywords: clinical research/practice; editorial/personal viewpoint; infection and infectious agents - viral: cytomegalovirus (CMV); infectious disease; kidney disease: infectious; kidney transplantation/nephrology; vaccine.
Comment on
-
A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor.Am J Transplant. 2018 Dec;18(12):2945-2954. doi: 10.1111/ajt.14925. Epub 2018 Jun 20. Am J Transplant. 2018. PMID: 29745007 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical